Abeona Therapeutics Inc.
Abeona Therapeutics Inc. (ABEO) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
abeo · stock forecast · 9 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 9 Wall Street analysts in the past 3 months
Buy
9 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$17.00
Consensus
$17.00
+216.0% upside
Low
$17.00
Median: $17 · Last Close: $5.38
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $5.40 | ↑ 0.36% |
1-day model range: $5.37–$5.43. Peak: $5.43 (+0.36%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $5 | -5.5% |
| 2028 | $5 | -8.4% |
| 2029 | $5 | -9.9% |
| 2030 | $5 | -10.7% |
| 2031 | — | -11.2% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ABEO · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-15 | Oppenheimer | Maintains | Outperform→Outperform |
| 2025-07-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-07-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-16 | Stifel | Maintains | Buy→Buy |
| 2025-04-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Abeona Therapeutics Inc. (ABEO) stock. Of the recent 39 rating actions, 1 were upgrades and 4 were downgrades. 9 analysts currently cover ABEO.
Analyst Recommendation Trends
ABEO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$66M
↓ 68.6% YoY
Revenue Next Year
$140M
↑ 110.6% YoY
EPS This Year
$-0.72
EPS Next Year
$-0.07
↓ 91.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast ABEO EPS of $-0.72 for the current fiscal year, based on estimates from 5 analysts. The ABEO revenue forecast is $66M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The ABEO stock forecast is supported by two independent data sources: analyst consensus ratings from 9 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus ABEO price target is $17.00 (+216.0% upside), with an analyst consensus of Buy.
The ABEO short-term stock prediction for tomorrow is $5.40 (+0.36%). The ABEO stock price prediction for 2027 estimates an average of $5. The ABEO stock prediction for 2030 projects a range of $5–$5.
Abeona Therapeutics Inc. trades on NASDAQ under the ticker ABEO. The ABEO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 67% of covering analysts.
Frequently asked questions
ABEO forecast · 8 questionsAccording to 9 Wall Street analysts, the average 12-month ABEO price target is $17.00, with a high forecast of $17.00 and a low of $17.00. The median price target is shown in the chart above when available. This implies +216.0% potential upside from the current price of $5.38.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.